Skip to main content
Erschienen in: Herz 7/2016

08.03.2016 | Original articles

Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD

verfasst von: C. Yu, M. Chen, Z. Chen, G. Lu

Erschienen in: Herz | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

The aim of this study was to examine the association between the admission neutrophil-to-lymphocyte ratio (N/L ratio) with coronary heart disease (CHD), separately from acute coronary syndrome (ACS) and stable angina (SA). A further aim was to investigate the clinical value of the N/L ratio in predicting in-hospital CHD events and the long-term prognosis of patients with CHD.

Patients and methods

In all, 942 patients were enrolled and classified into a CHD group (comprising an ACS group and an SA group) and a normal group. Laboratory data including regular blood test results were obtained at baseline. The relationship between the N/L ratio and CHD, ACS, Gensini score, and multivessel lesions was analyzed by logistic regression. Receiver operating characteristics (ROC) curve analysis was used to identify the value of the N/L ratio in the diagnosis of CHD, ACS, and the severity of CHD. We divided the patients into four groups according to the N/L ratio quartiles and compared the differences in major adverse cardiac events (MACEs) that occurred in hospital and in the 4.26 ± 0.57-year follow-up out of hospital.

Results

Patients with an elevated N/L ratio had a significantly increased risk of CHD [odds ratio (OR) = 1.697, 95 % confidence interval (CI) = 1.483–1.942], and an elevated N/L ratio was closely related to a higher risk of ACS (OR = 1.652, 95 % CI = 1.434–1.902). The admission N/L ratio (0.664; 95 % CI = 1.942–1.616) showed a greater ROC area than the WBC and LDL-C values. Patients with a higher N/L ratio in both the SA group and the ACS group had a higher incidence of in-hospital and out-of-hospital MACEs, including long-term mortality and occurrence of new-onset heart failure or re-occurrence of heart failure. An elevated N/L ratio on admission was also found to be a significant indicator of 4.26-year MACEs.

Conclusion

The admission N/L ratio was significantly associated with CHD and may become a risk predictor in the prognosis of patients with CHD.
Literatur
2.
Zurück zum Zitat Madjid M, Fatemi O (2013) Components of the complete blood count as risk predictors for coronary heart disease in-depth review and update. Tex Heart Inst J 40(1):17–29PubMedPubMedCentral Madjid M, Fatemi O (2013) Components of the complete blood count as risk predictors for coronary heart disease in-depth review and update. Tex Heart Inst J 40(1):17–29PubMedPubMedCentral
5.
Zurück zum Zitat Rashidi F, Rashidi A, Golmohamadi A, Hoseinzadeh E, Mohammadi B, Mirzajani H, Kheiri M, Jamshidi P (2008) Does absolute neutrophilia predict early congestive heart failure after acute myocardial infarction? A cross-sectional study. South Med J 101(1):19–23. doi:10.1097/SMJ.0b013e31815d3e11 CrossRefPubMed Rashidi F, Rashidi A, Golmohamadi A, Hoseinzadeh E, Mohammadi B, Mirzajani H, Kheiri M, Jamshidi P (2008) Does absolute neutrophilia predict early congestive heart failure after acute myocardial infarction? A cross-sectional study. South Med J 101(1):19–23. doi:10.​1097/​SMJ.​0b013e31815d3e11​ CrossRefPubMed
7.
Zurück zum Zitat Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, Kim MC, Hwang SH, Park KH, Lee MG, Ko JS, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC (2011) Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 107(6):849–856. doi:10.1016/j.amjcard.2010.10.067 CrossRefPubMed Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, Kim MC, Hwang SH, Park KH, Lee MG, Ko JS, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC (2011) Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 107(6):849–856. doi:10.​1016/​j.​amjcard.​2010.​10.​067 CrossRefPubMed
8.
Zurück zum Zitat Nunez J, Nunez E, Bodi V, Sanchis J, Minana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, Heatta AM, Llacer A (2008) Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 101(6):747–752. doi:10.1016/j.amjcard.2007.11.004 CrossRefPubMed Nunez J, Nunez E, Bodi V, Sanchis J, Minana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, Heatta AM, Llacer A (2008) Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 101(6):747–752. doi:10.​1016/​j.​amjcard.​2007.​11.​004 CrossRefPubMed
9.
Zurück zum Zitat Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, Lafferty J (2010) Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 106(4):470–476. doi:10.1016/j.amjcard.2010.03.062 CrossRefPubMed Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, Lafferty J (2010) Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 106(4):470–476. doi:10.​1016/​j.​amjcard.​2010.​03.​062 CrossRefPubMed
12.
Zurück zum Zitat Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRefPubMed Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRefPubMed
13.
Zurück zum Zitat Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F (2008) Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 395(1–2):27–31. doi:10.1016/j.cca.2008.04.019 CrossRefPubMed Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F (2008) Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 395(1–2):27–31. doi:10.​1016/​j.​cca.​2008.​04.​019 CrossRefPubMed
14.
Zurück zum Zitat Chavan V, Patil N, Karnik N (2007) Study of leukocytic hydrolytic enzymes in patients with acute stage of coronary heart disease. Indian J Med Sci 61(2):73–82CrossRefPubMed Chavan V, Patil N, Karnik N (2007) Study of leukocytic hydrolytic enzymes in patients with acute stage of coronary heart disease. Indian J Med Sci 61(2):73–82CrossRefPubMed
15.
Zurück zum Zitat Poludasu S, Cavusoglu E, Khan W, Marmur JD (2009) Neutrophil to lymphocyte ratio as a predictor of long‐term mortality in African Americans undergoing percutaneous coronary intervention. Clin Cardiol 32(12):E6–E10CrossRefPubMed Poludasu S, Cavusoglu E, Khan W, Marmur JD (2009) Neutrophil to lymphocyte ratio as a predictor of long‐term mortality in African Americans undergoing percutaneous coronary intervention. Clin Cardiol 32(12):E6–E10CrossRefPubMed
16.
Zurück zum Zitat Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, Walsh SR (2011) Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 45(3):227–231. doi:10.1177/1538574410396590 CrossRefPubMed Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, Walsh SR (2011) Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 45(3):227–231. doi:10.​1177/​1538574410396590​ CrossRefPubMed
17.
Zurück zum Zitat Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, Capodilupo R (2011) Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 107(3):433–438. doi:10.1016/j.amjcard.2010.09.039 CrossRefPubMed Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, Capodilupo R (2011) Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 107(3):433–438. doi:10.​1016/​j.​amjcard.​2010.​09.​039 CrossRefPubMed
19.
Zurück zum Zitat Nelson DH, Sandberg AA, Palmer JG, Tyler FH (1952) Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes. J Clin Invest 31(9):843–849. doi:10.1172/JCI102671 CrossRefPubMedPubMedCentral Nelson DH, Sandberg AA, Palmer JG, Tyler FH (1952) Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes. J Clin Invest 31(9):843–849. doi:10.​1172/​JCI102671 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gibson P, Croal B, Cuthbertson B, Small G, Ifezulike A, Gibson G, Jeffrey R, Buchan K, El-Shafei H, Hillis G (2007) Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 154(5):995–1002. doi:10.1016/j.ahj.2007.06.043 CrossRefPubMed Gibson P, Croal B, Cuthbertson B, Small G, Ifezulike A, Gibson G, Jeffrey R, Buchan K, El-Shafei H, Hillis G (2007) Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 154(5):995–1002. doi:10.​1016/​j.​ahj.​2007.​06.​043 CrossRefPubMed
22.
Metadaten
Titel
Predictive and prognostic value of admission neutrophil-to-lymphocyte ratio in patients with CHD
verfasst von
C. Yu
M. Chen
Z. Chen
G. Lu
Publikationsdatum
08.03.2016
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 7/2016
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-015-4399-8

Weitere Artikel der Ausgabe 7/2016

Herz 7/2016 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.